Tag: health care

Chemotherapy kills cancer patients faster than no treatment at all

Wishful thinking simply won’t deter from the fact that the cancer industry is just that: an industry. Doctors, drug companies, hospitals and other key stakeholders profit heavily each time a cancer patient submits to the conventional treatment model, which typically involves injecting chemotherapy poisons into the body, blasting it with ionizing radiation or cutting off body parts — or some barbaric combination of all three.

It might rub some people the wrong way to state this, especially those who’ve had to watch a loved one die from conventional cancer treatment, but each of these supposed treatments don’t actually work, in many cases. Little-known science, which the medical-industrial complex has made it a practice to ignore or cover up, reveals that, despite what the medical industry often claims, chemotherapy in particular just isn’t an effective cancer treatment.

Dr. Hardin B. Jones, a former professor of medical physics and physiology at the University of California, Berkeley, had been studying the lifespans of cancer patients for more than 25 years when he came to the conclusion that, despite popular belief, chemotherapy doesn’t work. He witnessed a multitude of cancer patients treated with the poison die horrific deaths, many of them meeting their fate much earlier than other patients who chose no treatment at all.

After investigating this further, Dr. Jones found that cancer patients who underwent chemotherapy actually died more quickly, in most cases, than those who followed their doctors’ recommendations by getting the treatment. A few number-crunching efforts later and Dr. Jones exposed a fact that the conventional cancer industry doesn’t want the world to know about its multi-billion-dollar cash cow.

“People who refused treatment lived for an average of 12 and a half years,” stated Dr. Jones about his study’s findings, which were published in the journal Transactions of the New York Academy of Sciences. “Those who accepted other kinds of treatment lived on an average of only 3 years.”

Keep reading

Atlanta Could Add Psilocybin And Ketamine To City Workers’ Healthcare Plans Under Pending Resolution

A new proposal from an Atlanta City Council member would direct municipal officials to explore the pros and cons of adding coverage for psilocybin and ketamine as mental health treatments to the city’s healthcare plan for firefighters, police and other government workers.

“Traditional treatments for mental illnesses such as depression, anxiety, PTSD, and others have shown limited effectiveness for some individuals, leading to a need for exploring alternative therapeutic options,” the legislation, which is currently being sponsored by 11 of the Council’s 16 members, states. “Recent research has demonstrated the potential efficacy of alternative therapies such as ketamine-assisted therapy and psilocybin-assisted therapy in treating various mental health conditions, offering promising results where other treatments have failed.”

The resolution’s lead sponsor, Councilmember Liliana Bakhtiari, has said city workers deserve access to a broad range of mental health services.

“We should be offering our employees—and especially our first responders, who are expected to be superhuman—the same amount of grace and providing them with a tool set to essentially overcome this issue,” The lawmaker recently told Axios.

Bakhtiari said the impetus for including the drugs on public employees’ health plans was meeting a West Virginia police officer who witnessed a fellow officer die of suicide and later used ketamine to treat his PTSD. The lawmaker said they’re not aware of any other city governments that have looked into covering psilocybin or ketamine treatment.

The resolution from Bakhtiari would request the Atlanta’s human resources department to “explore the feasibility of adding coverage for ketamine therapy, psilocybin therapy, and other alternative therapies for mental illness in the City’s employee benefits contract during its next round of negotiations.”

Keep reading

‘A Failed Medical School’: How Racial Preferences, Supposedly Outlawed in California, Have Persisted at UCLA

Long considered one of the best medical schools in the world, the University of California, Los Angeles’s David Geffen School of Medicine receives as many as 14,000 applications a year. Of those, it accepted just 173 students in the 2023 admissions cycle, a record-low acceptance rate of 1.3 percent. The median matriculant took difficult science courses in college, earned a 3.8 GPA, and scored in the 88th percentile on the Medical College Admissions Test (MCAT).

Without those stellar stats, some doctors at the school say, students can struggle to keep pace with the demanding curriculum.

So when it came time for the admissions committee to consider one such student in November 2021—a black applicant with grades and test scores far below the UCLA average—some members of the committee felt that this particular candidate, based on the available evidence, was not the best fit for the top-tier medical school, according to two people present for the committee’s meeting.

Their reservations were not well-received.

When an admissions officer voiced concern about the candidate, the two people said, the dean of admissions, Jennifer Lucero, exploded in anger.

“Did you not know African-American women are dying at a higher rate than everybody else?” Lucero asked the admissions officer, these people said. The candidate’s scores shouldn’t matter, she continued,  because “we need people like this in the medical school.”

Even before the Supreme Court’s landmark affirmative action ban last year, public schools in California were barred by state law from considering race in admissions. The outburst from Lucero, who discussed race explicitly despite that ban, unsettled some admissions officers, one of whom reached out to other committee members in the wake of the incident. “We are not consistent in the way we apply the metrics to these applicants,” the official wrote in an email obtained by the Washington Free Beacon. “This is troubling.”

“I wondered,” the official added, “if this applicant had been [a] white male, or [an] Asian female for that matter, [whether] we would have had that much discussion.”

Since Lucero took over medical school admissions in June 2020, several of her colleagues have asked the same question. In interviews with the Free Beacon and complaints to UCLA officials, including investigators in the university’s Discrimination Prevention Office, faculty members with firsthand knowledge of the admissions process say it has prioritized diversity over merit, resulting in progressively less qualified classes that are now struggling to succeed.

Race-based admissions have turned UCLA into a “failed medical school,” said one former member of the admissions staff. “We want racial diversity so badly, we’re willing to cut corners to get it.”

This story is based on written correspondence between UCLA officials, internal data on student performance, and interviews with eight professors at the medical school—six of whom have worked with or under Lucero on medical student and residency admissions.

Together, they provide an unprecedented account of how racial preferences, outlawed in California since 1996, have nonetheless continued, upending academic standards at one of the top medical schools in the country. The school has consequently taken a hit in the rankings and seen a sharp rise in the number of students failing basic standardized tests, raising concerns about their clinical competence.

“I have students on their rotation who don’t know anything,” a member of the admissions committee told the Free Beacon. “People get in and they struggle.”

Keep reading

Childhood Vaccine Schedule Led to ‘Greatest Decline in Public Health in Human History’

A U.S. Senate roundtable discussion, hosted by Sen. Ron Johnson, tackled a taboo topic — why public health agencies have not studied the health outcomes of vaccinated versus unvaccinated children — and have refused to make data on the topic available to the public.1

“They do not publish the results [or] let any independent scientist in to look at that information,” Brian Hooker, chief scientific officer for Children’s Health Defense, said. “They refuse to publish the results and they really know why. It’s because the bloated vaccination schedule is responsible and is, I would say, in part responsible for the epidemic of chronic disorders that we see in children in the U.S.”2

In 1962, children received just five vaccine doses. As of 2023, children up to age 18 receive 73 doses of 16 different vaccines. The cumulative effects of this childhood vaccine schedule have never been tested.

Keep reading

The Dam Is Breaking on Medical Trafficking Evidence – The Blood Was Contaminated

For the last four years, global citizens have been forced, coerced, defrauded and lied to about the COVID-19 vascular, neurological and severe cardio injuries, but this month, the damn has broken further about the endless greed associated with medical corruption about who knew what when it comes to medical trafficking and known medical corruption for decades. 

It should be a massive wake-up call for those who are in denial that governments, the medical industry, and PHARMA are incapable of lying to the public and citizens should just believe in the medical divinity of those in white coats. 

This week in the UK a cataclysmic story broke when the UK Inquiry on Blood Contamination released its findings. It is a stunning story about people in the know keeping their mouths shut and going about their jobs selling, profiting and administering blood transfusions since the 1970s to innocent human beings in dire need that resulted in Hep C to HIV and other diseases, and resulted in horrific deaths that affected loved ones and family caretakers. 

The 2,000-plus page report was released on Monday. The summary alone is devastating blow to humanity and has brought shame upon the UK bureaucrats elected to protect their citizens via regulatory agencies and the medical industry’s lack of ethical standards. 

In the 1970s, the UK was in need of blood and imported it – some from the U.S. The blood was sold and known to be contaminated by some in the know, who chose to remain silent. 

By the mid-1970s, there were repeated warnings that imported US Factor VIII carried greater risk of infection and the UK’s NHS continued to use foreign supplies. For a summary of the findings, as reported by Sky News watch this short report. 

Sir Brian Langstaff, a former High Court Judge, led the inquiry since 2017 across the U.K. He stated that thousands of patients were admitted to hospitals and ended up with “life shattering” medical complications. 

His announcement of the findings publicly can be watched here.

Keep reading

Many countries have reached the point of over-medication

The fact that hospital waiting lists are increasing all the time, that the amount of sick leave taken by working men and women seems to rise each year, that mental illnesses are getting commoner every time statistics are brought up to date, that the incidence of heart disease seems to be on the increase, that there is a massive increase in the amount of pollutant-inspired illness, that 80 per cent of modern cancers are thought to be caused by chemicals of one sort or another, and that the number of health professionals needed to cope with all the sickness is increasing rapidly, seem to suggest that medical research has had relatively little effect on the morbidity rates or upon the quality of life at any time in the last century.

In addition, there is evidence that medical research has actually detracted from the quality of life, causing ethical problems and using funds which could be better used on projects more likely to contribute to good health.

Indeed, there is not only evidence for the uselessness of much medical research: there are also sound indications that many developed countries have reached a point of over-medication which is harmful to health. As Dr. Vernon Coleman pointed out in his book ‘Coleman’s Laws’, if a patient has two conditions – two diseases – there is a very good chance that one of those diseases was caused by the treatment for the other.

Writing in the Journal of Human Resources, an American researcher, Charles T. Stewart, has shown that life expectation is approximately the same in countries with between 4 and 16 doctors per 10,000 people. It is a certain fact that while the number of patients treated by doctors is increasing in numerical terms, the number saved as a percentage of those who could be saved is falling dramatically.

There is a savage irony in the fact that we have now reached the point where, on balance, well-meaning doctors in general practice, and highly trained, well-equipped specialists working in hospitals, may do more harm than good. The epidemic of iatrogenic disease which has always scarred medical practice has been steadily getting worse and today most of us would, most of the time, be better off without a medical profession.

Keep reading

More than 30 Babies Mistakenly Vaccinated with Pfizer or GSK’s RSV Shots

At least 34 babies were mistakenly given the respiratory syncytial virus (RSV) vaccine and one of those babies was hospitalized according to a study published today in Pediatrics.

Researchers from the Centers for Disease Control and Prevention (CDC) analyzed data from the Vaccine Adverse Event Reporting System (VAERS) for the RSV vaccines, which are not approved for children.

The researchers found 27 reports of the Pfizer RSV vaccine (Abrysvo) and seven reports of the GSK RSV vaccine (Arexvy) mistakenly administered to children under 2 between Aug. 21, 2023, and March 18, 2024.

“While rare, vaccine administration errors are known to occur and may increase after a new vaccine or product is introduced,” Dr. Pedro Moro, lead author of the study, told MedPage Today.

Both vaccines were first approved in May 2023 for people ages 60 and older. Pfizer’s Abrysvo was approved in August 2023 for pregnant mothers during part of their third trimester, targeting RSV prevention in babies.

Keep reading

Biden HHS Redefines ‘Lawfully Present’ To Give ‘Free’ Health Care To Illegal Immigrants

So much for a border crisis. The Biden administration recently finalized regulations that will provide taxpayer-funded benefits to individuals who came into this country lacking authorization, by defining them as “lawfully present.”

The final rule follows regulations proposed last spring. It will have the same major effects as the initial proposal by expanding access to taxpayer health benefits for specified populations, but seems craftily drafted in a way to avoid, or at least minimize, legal challenges.

Medicaid Expansion Not Finalized

The prime controversy in both last year’s proposed rule and this year’s final version is over health coverage for individuals participating in the Deferred Action for Childhood Arrivals (DACA) program. Both regulations would revise the definition of “lawfully present” to include DACA participants for purposes of participation in health programs under Obamacare.

One major difference lies in the applicability of the regulatory changes. Whereas last year’s proposed rule changed the definition of “lawfully present” for both the insurance exchanges and Medicaid, the final regulation only applied the change to the exchanges, at least for the moment.

As a practical matter, not finalizing the Medicaid change will have little impact on DACA participants. Unlike most other populations, DACA participants will not need to earn income equal to the poverty level ($15,060 for a single person in 2024) to qualify for exchange subsidies. And because Biden-era enhanced subsidies remain in effect next year, the lowest-income recipients can qualify for subsidies that require no out-of-pocket premium for a benchmark health plan.

Keep reading

Largest Review On Transgender-Youth Medicine Finds Insufficient Evidence For Medicalization

England may be the third country to withdraw from a “gender-affirming” treatment pathway due to recommendations from a long-awaited report.

In April, the country published the Cass Review, “most comprehensive summary on transgender-youth medicine,” psychologist Erica Anderson, who identifies as transgender and has a doctorate in clinical psychology, told The Epoch Times.

The review, chaired by Dr. Hilary Cass, British honorary physician, consultant in pediatric disability, and former president of the Royal College of Paediatrics and Child Health, stated that there is insufficient evidence to demonstrate the long-term benefits of medicalizing children who want to identify as a different gender. Instead, the review recommends focusing on psychotherapy.

For some clinicians and researchers, this recommendation was a long time coming. Others are concerned that it potentially threatens medicalization—currently the primary treatment—for gender-incongruent youths.

The National Health Service (NHS) England, which commissioned the report in 2020, stated it would be committed to following through on the recommendations.

“[The Cass Review] final report will not just shape the future of healthcare in this country for children and young people experiencing gender distress but will be of major international importance and significance,” the statement read.

Eight days after the Cass Review’s release, Scotland’s health boards announced a pause on new prescriptions for puberty blockers and cross-sex hormones as they gather evidence to support the safety and clinical effectiveness of these medications.

Keep reading

Historic Drug Shortage Exacerbated by EPA Overreach

Concerning new reports reveal that the drug shortage in the U.S. has reached its highest level since the American Society of Health-System Pharmacists began tracking data. In total, 323 medicines are now in short supply.

However, the problem is about to get worse because of government regulations on an entirely different issue. Counterintuitive measures from the Environmental Protection Agency (EPA) are set to effectively ban the domestic production of chemicals that are used in the process of manufacturing vital prescription drugs and vaccines.

Shortly after Congress amended the Toxic Substances Control Act (TSCA) in 2016, the EPA began the rulemaking process on 10 chemicals currently in use in the United States using a broad and overreaching definition of “unreasonable risk.” Now, the EPA is expected to release a final rule on methylene chloride under TSCA.

Methylene chloride has several applications, including in the process of manufacturing hundreds of medicines and vaccines like those that treat Hepatitis B and HIV infections, mental illnesses and epilepsy, heart failure and high blood pressure, and high cholesterol.

If this rule goes into effect, it will exacerbate the drug shortage by bringing domestic manufacturing to a halt while making our supply chains more reliant on foreign nations like China for pharmaceuticals. This runs in direct contradiction to the Biden administration’s “Investing in America” agenda, which aims to onshore supply chains critical to our economy and security.

For example, methylene chloride is used to make hollow fiber cartridges which are used in the manufacture of monoclonal antibodies and vaccines, including the COVID-19, HPV, Hepatitis B, and flu vaccines, as well as therapies for arthritis, migraines, osteoporosis, and autoimmune diseases. In a letter to the EPA, the company that produces these cartridges wrote their product is used in at least 190 human therapeutics and vaccines. Their supply is so essential that the U.S. Department of Health and Human Services and the Defense Department awarded the company funding to expand its manufacturing capacity here in the U.S.

Keep reading